Aklillu Eleni, Carrillo Juan Antonio, Makonnen Eyasu, Bertilsson Leif, Djordjevic Natasa
Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge C1:68, SE-141 86, Stockholm, Sweden.
Division of Clinical Pharmacology, Department of Medical and Surgical Therapeutics, Medical School, University of Extremadura, Badajoz, Spain.
Eur J Clin Pharmacol. 2018 Jul;74(7):903-911. doi: 10.1007/s00228-018-2448-y. Epub 2018 Mar 27.
N-acetyltransferase 2 (NAT2) metabolize several drugs including isoniazid. We investigated the effect of genotype, geographical difference, and smoking habit on NAT2 phenotype in Ethiopians.
Genotyping for NAT2 191G > A, 341 T > C, 590G > A, and 857G > A was performed in 163 unrelated healthy Ethiopians (85 living in Ethiopia and 78 living in Sweden). The NAT2 phenotype was determined using caffeine as a probe and log AFMU/(AFMU + 1X + 1 U) urinary metabolic ratio (MR) as an index.
The frequencies of NAT2*4, *5, *6, *7, and 14 haplotypes were 14.1, 48.5, 30.1, 5.5, and 1.8%, respectively. The frequencies of rapid (NAT24/*4), intermediate (heterozygous *4), and slow (no *4 allele) acetylator genotypes were 1.8, 24.6, and 73.6%, respectively. The distribution NAT2 MR was bimodal with 70% being phenotypically slow acetylators. NAT2 genotype (p < 0.0001) and country of residence (p = 0.004) independently predicted NAT2 phenotype. Controlling for the effect of genotype, ethnic Ethiopians living in Ethiopia had significantly higher NAT2 MR than those living in Sweden (p = 0.006). NAT2 genotype-phenotype concordance rate was 75%. Distinct country-of-residence-based genotype-phenotype discordance was observed. The proportion of phenotypically determined rapid acetylators was significantly higher and slow acetylators was lower in Ethiopians living in Ethiopia (39% rapid, 61% slow) than in Sweden (20% rapid, 80% slow). Sex and smoking had no significant effect on NAT2 MR.
We report a high prevalence of NAT 2 slow acetylators in Ethiopians and a conditional NAT2 genotype-phenotype discordance implicating a partial phenotype conversion and metabolic adaptation. Gene-environment interactions regulate NAT2 phenotype.
N-乙酰基转移酶2(NAT2)可代谢包括异烟肼在内的多种药物。我们研究了基因型、地域差异和吸烟习惯对埃塞俄比亚人NAT2表型的影响。
对163名无亲缘关系的健康埃塞俄比亚人(85名生活在埃塞俄比亚,78名生活在瑞典)进行NAT2 191G>A、341T>C、590G>A和857G>A的基因分型。以咖啡因作为探针,采用对数AFMU/(AFMU + 1X + 1U)尿代谢率(MR)作为指标来确定NAT2表型。
NAT2 *4、*5、*6、7和14单倍型的频率分别为14.1%、48.5%、30.1%、5.5%和1.8%。快速(NAT2 4/4)、中间型(杂合子4)和慢速(无4等位基因)乙酰化基因型的频率分别为1.8%、24.6%和73.6%。NAT2 MR的分布呈双峰型,70%为表型慢速乙酰化者。NAT2基因型(p<0.0001)和居住国(p = 0.004)可独立预测NAT2表型。在控制基因型影响后,生活在埃塞俄比亚的埃塞俄比亚人NAT2 MR显著高于生活在瑞典的人(p = 0.006)。NAT2基因型与表型的一致性率为75%。观察到基于居住国的明显基因型与表型不一致。生活在埃塞俄比亚的埃塞俄比亚人中,表型确定的快速乙酰化者比例显著高于瑞典人(39%快速,61%慢速),而慢速乙酰化者比例则低于瑞典人(20%快速,80%慢速)。性别和吸烟对NAT2 MR无显著影响。
我们报道了埃塞俄比亚人NAT2慢速乙酰化者的高患病率以及有条件的NAT2基因型与表型不一致,这意味着部分表型转换和代谢适应。基因-环境相互作用调节NAT2表型。